-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 DrznnqGyjGKMc8HB5v36Z6/0orYwhuCmfXECxX8cZ2YM1kWq0IE9vTOeJ6uaskft
 dS+jtR/n/io6CMui1WHrPQ==

<SEC-DOCUMENT>0001019687-05-003336.txt : 20051205
<SEC-HEADER>0001019687-05-003336.hdr.sgml : 20051205
<ACCEPTANCE-DATETIME>20051205161711
ACCESSION NUMBER:		0001019687-05-003336
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20051201
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20051205
DATE AS OF CHANGE:		20051205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOMERICA INC
		CENTRAL INDEX KEY:			0000073290
		STANDARD INDUSTRIAL CLASSIFICATION:	DENTAL EQUIPMENT & SUPPLIES [3843]
		IRS NUMBER:				952645573
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-08765
		FILM NUMBER:		051244391

	BUSINESS ADDRESS:	
		STREET 1:		1533 MONROVIA AVENUE
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92663
		BUSINESS PHONE:		9496452111

	MAIL ADDRESS:	
		STREET 1:		1533 MONROVIA AVENUE
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92663

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NMS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19871130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR MEDICAL SYSTEMS INC
		DATE OF NAME CHANGE:	19830216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR INSTRUMENTS INC
		DATE OF NAME CHANGE:	19720508
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>biomerica_8k-120105.txt
<TEXT>
<PAGE>

                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

                                December 1, 2005
                Date of Report (date of earliest event reported)


                                 BIOMERICA, INC.
                                 ---------------
             (Exact Name of Registrant as Specified in its Charter)

     Delaware                       0-8765                   95-2645573
     --------                       ------                   ----------
     (State or Other                (Commission              (IRS Employee
     Jurisdiction of                File Number)             Identification
                                                             Number)

                              1533 Monrovia Avenue
                         Newport Beach, California 92663
                         -------------------------------
                     (Address of Principal Executive Offices
                               Including Zip Code)

                                  949-645-2111
                                  ------------
                         (Registrant's Telephone Number,
                              Including Area Code)


                                   __________
                    (Former Name or Former Address if Changed
                               Since Last Report)


<PAGE>


Table of Contents:
- ------------------
8.01 Other Events.


Item 8.01 Other Events.

     Historically, certain Biomerica, Inc. ("Biomerica"), board members who
owned shares of common stock of Lancer Orthodontics, Inc. ("Lancer"), had agreed
to vote their shares of Lancer common stock in the same manner as the Biomerica
board voted its shares of Lancer common stock for issues requiring the vote of
Lancer's stockholders. These agreements, when combined with Biomerica's
ownership interests in Lancer, resulted in Biomerica controlling over 50% of
Lancer's voting securities and a consolidation of Lancer's financial statements
into Biomerica's financial statements. As of December 1, 2005, the
above-mentioned Biomerica board members reserved their right no longer to vote
their shares of Lancer in the same manner as the Biomerica board votes
Biomerica's shares of Lancer. Therefore, effective as of December 1, 2005,
Lancer's financial statements will no longer be consolidated with those of
Biomerica because Biomerica will no longer have direct or indirect control of
more than 50% of Lancer's common stock. As of December 1, 2005, Biomerica holds
less than 20% of Lancer's common stock and therefore Biomerica's investment in
Lancer will be accounted for using the cost method.



                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

BIOMERICA, INC.

Dated: December 1, 2005             By: /s/ Zackary S. Irani
                                        --------------------
                                    Name: Zackary S. Irani
                                          ----------------
                                    Title:  Chief Executive Officer


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
